Testing effectiveness (Phase 2)Study completedNCT01443065
What this trial is testing
MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma
Who this might be right for
Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach
UNICANCER 162